Roy Vergis

Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study

Roy Vergis, Catherine M. Corbishley, A. Norman et al. · The Lancet Oncology · 2008 · 278 citations · Full text

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

Janet E. Brown, Kara‐Louise Royle, Walter M. Gregory et al. · The Lancet Oncology · 2023 · 76 citations · Full text

Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer

Alison Reid, Gerhardt Attard, Daniel Brewer et al. · Modern Pathology · 2012 · 49 citations · Full text

Urology, Medicine, Cancer Genomics +7

Expression of Bcl-2, p53, and MDM2 in Localized Prostate Cancer With Respect to the Outcome of Radical Radiotherapy Dose Escalation

Roy Vergis, Catherine M. Corbishley, Karen Thomas et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 32 citations

Urology, Radiation Therapy, Medicine +7

An improved method for constructing tissue microarrays from prostate needle biopsy specimens

Frank McCarthy, Ashley A. Fletcher, Nening M. Dennis et al. · Journal of Clinical Pathology · 2009 · 11 citations · Full text